Fresenius Group Overview

  • FY 2017 Results

    Fresenius reports 14th consecutive record year, aims at strong growth in 2018

New Developments

Financial Highlights

Sales

€ 33.9 bn

+16%1

FY/2016: €29.5 bn

EBITDA2

€ 6267 m

+15%1

FY/2016: €5,517 m

EBIT2

€ 4830 m

+14%1

FY/2016: €4,302 m

Employees

273,249

Dec. 31, 2016: 232,873

Net Income3

€ 1859 m

+21%1

FY/2016: €1,560 m

Earnings per Share3

€ 3.35

+19%1

FY/2016: €2.85

 

1 In constant currency

2 Before special items

3 Net income attributable to shareholders of Fresenius SE & Co. KGaA; consistent with scope of original guidance: before acquisition-related expenses; before expenditures for further development of biosimilars business; book gain from U.S. tax reform and FCPA provision

CEO message

“Our business results reflect our successful work for people. Record sales and earnings in 2017, along with the company’s strong guidance for this year and through 2020, show that our uncompromising focus on patients and quality also pays for our investors.”


Stephan Sturm, Chairman of the Management Board 

  • Business Segments

    • 9% sales growth in constant currency, 7% adjusted net income growth in constant currency
    • 13% operating cash flow growth
    • 2018 outlook: ~8% sales growth in constant currency and 13 to 15% net income growth in constant currency expected

  • Business Segments

    • 7% organic sales growth, 8% EBIT growth in constant currency
    • Operating cash flow at all-time high
    • 2018 outlook: 4% to 7% organic sales growth and -3% to -6% EBIT growth in constant currency expected (~2% to 5% excl. biosimilars expenses)

  • Business Segments

    • 4% organic sales growth
    • 54% EBIT increase (6% excluding Quirónsalud)
    • 2018 outlook: 3% to 6% organic sales growth and EBIT growth of 7% to 10% expected

  • Business Segments

    • 6% organic sales growth, 10% EBIT growth
    • Order intake of €1,096 million at all-time high
    • 2018 outlook: 5% to 10% organic sales growth and 5% to 10% EBIT growth expected

News

All Financial Reports